166 related articles for article (PubMed ID: 25339833)
1. Gene expression profile of peripheral blood in colorectal cancer.
Chang YT; Huang CS; Yao CT; Su SL; Terng HJ; Chou HL; Chou YC; Chen KH; Shih YW; Lu CY; Lai CH; Jian CE; Lin CH; Chen CT; Wu YS; Lin KS; Wetter T; Chang CW; Chu CM
World J Gastroenterol; 2014 Oct; 20(39):14463-71. PubMed ID: 25339833
[TBL] [Abstract][Full Text] [Related]
2. Verification of gene expression profiles for colorectal cancer using 12 internet public microarray datasets.
Chang YT; Yao CT; Su SL; Chou YC; Chu CM; Huang CS; Terng HJ; Chou HL; Wetter T; Chen KH; Chang CW; Shih YW; Lai CH
World J Gastroenterol; 2014 Dec; 20(46):17476-82. PubMed ID: 25516661
[TBL] [Abstract][Full Text] [Related]
3. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.
Findeisen P; Röckel M; Nees M; Röder C; Kienle P; Von Knebel Doeberitz M; Kalthoff H; Neumaier M
Int J Oncol; 2008 Nov; 33(5):1001-10. PubMed ID: 18949363
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.
Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H
Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794
[TBL] [Abstract][Full Text] [Related]
5. Limits of predictive models using microarray data for breast cancer clinical treatment outcome.
Reid JF; Lusa L; De Cecco L; Coradini D; Veneroni S; Daidone MG; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2005 Jun; 97(12):927-30. PubMed ID: 15956654
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a blood-based 18-gene expression signature in colorectal cancer.
Xu Y; Xu Q; Yang L; Ye X; Liu F; Wu F; Ni S; Tan C; Cai G; Meng X; Cai S; Du X
Clin Cancer Res; 2013 Jun; 19(11):3039-49. PubMed ID: 23536436
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
9. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
10. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
13. [Functional mRNA expression analysis and classification of colonic biopsy samples using overall cDNA microarray technique].
Galamb O; Sipos F; Dinya E; Spisák S; Somorácz A; Molnár B; Tulassay Z
Orv Hetil; 2008 Feb; 149(5):219-32. PubMed ID: 18218589
[TBL] [Abstract][Full Text] [Related]
14. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of osteoprotegerin expression in human colorectal cancer.
Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
17. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
18. Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling.
Zhao YP; Ruan CP; Wang H; Hu ZQ; Fang M; Gu X; Ji J; Zhao JY; Gao CF
Cancer; 2012 Feb; 118(3):639-50. PubMed ID: 21853445
[TBL] [Abstract][Full Text] [Related]
19. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]